Chesapeake Asset Management »

Crispr Therapeutics shares owned by Chesapeake Asset Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Chesapeake Asset Management from 13F filings

Historical chart of Chesapeake Asset Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Chesapeake Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Chesapeake Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $11k 200 52.44